Drug patch definition

Drug patch means an absorbent body perspiration collection patch used to detect the presence of controlled substances, including cocaine, marijuana, amphetamines, methamphetamine, phencyclidine, barbiturates, benzodiazepines, methadone, and opiates, including heroin, morphine, codeine, hydrocodone, and oxycodone.
Sample 1Sample 2Sample 3
Drug patch means any type of device affixed to a person's skin to test for the presence of controlled substances in the person's body.
Sample 1Sample 2Sample 3
Drug patch means any type of device that is affixed to a person’s skin that tests for the presence of a controlled substance, as defined in W.S. § 35-7-1002(a)(iv), in the participant’s body;
Sample 1Sample 2

Examples of Drug patch in a sentence

  • For example, although the complaint’s allegations related primarily to the products BioTherapex and NeuroPlus, Section I of the Judgment prohibits certain representations relating to “any Dietary Supplement, over-the-counter Drug, patch, cream, wrap, or other product worn on the body or rubbed into the skin.” Id. at 6.

  • Drug patch testing in systemic cutaneous drug allergy.Toxicology 2005; 209: 209–16.

  • However there is one exception to this; in the instance of application of a Controlled Drug patch being delegated to Domiciliary Care Workers, a Community Nurse must go through a checklist for the individual service user with the workers involved as part of the governance arrangements (Appendix 7).


More Definitions of Drug patch

Drug patch means an absorbent body perspiration collection patch used to detect the metabolite of controlled substances.
Sample 1Sample 2
Drug patch means any type of device affixed to a per- son’s skin to test for the presence of controlled substances in the person’s body.
Sample 1
Drug patch means any type of device that is affixed to a
Sample 1
Drug patch means an adhesive patch affixed to the skin for a set number of days that uses sweat to detect the parent drug and drug metabolite.
Sample 1

Related to Drug patch

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether

  • Drug sample means a unit of a prescription drug that is not intended to be sold and is intended to promote the sale of the drug.

  • Drug Substance means an active ingredient that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Finished Product means a cannabis product in its final form to be sold at a retail premises.

  • API means the American Petroleum Institute.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Batch means a specific quantity of Product that is intended to be of uniform character and quality, within specified limits, and is produced during the same cycle of Manufacture as defined by the applicable Batch Record.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • ANDA means Abbreviated New Drug Application.

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Manufacturing Process means any process for—

  • Aerosol Product means a pressurized spray system that dispenses product ingredients by means of a propellant contained in a product or a product's container, or by means of a mechanically induced force. “Aerosol Product” does not include “Pump Spray.”

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Drug Approval Application means an application for Regulatory Approval required before commercial sale of a Product as a pharmaceutical product in a regulatory jurisdiction.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Licensed Compound means [***].

  • Drug means (i) articles or substances recognized in the official United States Pharmacopoeia

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • DMF means a drug master file and all equivalents, and related proprietary dossiers, in any country or jurisdiction in the Territory (including any active substance master file in the EMA) for API submitted or to be submitted by a Party to Regulatory Authorities.

  • Drug Application means a new drug application, an abbreviated drug application, or a product license application for any Product, as appropriate, as those terms are defined in the FDCA.

  • Tobacco product manufacturer means an entity that after the date of enactment of this Act directly (and not exclusively through any affiliate):